## Abstract Xenalipin 1 (4β²βtrifluoromethylβ2βbiphenylcarboxylic acid) was synthesized in the [^14^C]βlabelled form with specific activity 21.0 mCi/mmol suitable for metabolism and distribution studies in animals. The synthetic sequence involved conversion of [^14^C]β benzoic acid to the 4,4βdimeth
Metabolic effects of a new hypolipidemic agent, ciprofibrate
β Scribed by Aaron Arnold; John P. McAuliff; Arthur L. Beyler
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 257 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis C virus (HCV) relies on host lipid metabolic pathways for its replication, assembly, secretion, and entry. HCV induces de novo lipogenesis, inhibits Ξ²-oxidation, and lipoprotein export resulting in a lipid-enriched cellular environment critical for its proliferation. We investigated the ef
We have evaluated the effects of repaglinide, a new non-sulphonylurea oral hypoglycaemic agent that has a stimulatory effect on insulin secretion. Forty-four patients with NIDDM, already treated with a sulphonylurea, took part in an open, randomised, group comparison study of 12 weeks duration, duri
## Abstract Controversial data on the lipidβlowering effect of dietary pea proteins have been provided and the mechanisms behind this effect are not completely understood. The aim of the study was to evaluate a possible hypolipidemic activity of a pea protein isolate and to determine whether pea pr